Qube Research & Technologies Ltd

Position in RGNX — REGENXBIO Inc.

CIK 1729829 LONDON, X0

Position in RGNX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$10,981,931

+$4,607,195 QoQ

Shares Held

1,310,493

+196.0% QoQ

Ownership

2.53%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Qube Research & Technologies Ltd holds $2,033,804,065 across 186 Biotechnology names. RGNX ranks #48 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	838,187	$277,330,932
2	FOLD	AMICUS THERAPEUTICS, INC.	8,809,340	$127,383,056
3	ROIV	Roivant Sciences Ltd.	3,450,904	$95,590,040
4	RPRX	Royalty Pharma plc	1,524,511	$73,130,792
5	REGN	Regeneron Pharmaceuticals, Inc.	83,358	$64,405,725
6	AXSM	Axsome Therapeutics, Inc.	335,334	$56,678,152
7	RVMD	Revolution Medicines, Inc.	553,290	$53,807,452
8	CYTK	Cytokinetics Inc	779,446	$51,373,285

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,981,931	1,310,493	+196.0%	Shares	Sole	2026-05-15
2025-12-31	$6,374,736	442,690	+55.4%	Shares	Sole	2026-02-17
2025-09-30	$2,748,619	284,831	-37.7%	Shares	Sole	2025-11-14
2025-06-30	$3,752,889	457,112	+16.4%	Shares	Sole	2025-08-14
2025-03-31	$2,808,484	392,795	+11.0%	Shares	Sole	2025-05-15
2024-12-31	$2,736,365	353,993	+82.4%	Shares	Sole	2025-02-14
2024-09-30	$2,035,836	194,074	+76.5%	Shares	Sole	2024-11-14
2024-06-30	$1,286,789	109,982	+155.9%	Shares	Sole	2024-08-14
2024-03-31	$905,420	42,972	+126.9%	Shares	Sole	2024-05-14
2023-12-31	$339,937	18,938	-56.5%	Shares	Sole	2024-02-13
2023-03-31	$822,414	43,491	+17.4%	Shares	Sole	2023-05-15
2022-12-31	$840,407	37,055	+146.3%	Shares	Sole	2023-02-14
2021-03-31	$513,184	15,045	—	Shares	Sole	2021-05-14
No filing history on record for this holder in this stock.